- 2024-08-20 02:19镱|Ytterbium|7440-64-4|Merck|99%|1EA
- 2024-08-20 02:19镱|Ytterbium|7440-64-4|Merck|99%|1EA
- 2024-08-20 02:19抑制剂β-Amyrone|β-Amyrone|638-97-1|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:19抑制剂β-Amyrone|β-Amyrone|638-97-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:19抑制剂β-Amyrone|β-Amyrone|638-97-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:19抑制剂α-Lapachone|α-Lapachone|4707-33-9|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:19抑制剂β-Amyrin acetate|β-Amyrin acetate|1616-93-9|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:19抑制剂β-Amyrin acetate|β-Amyrin acetate|1616-93-9|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:19抑制剂β-Amyrin acetate|β-Amyrin acetate|1616-93-9|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:19抑制剂α-Amyrin acetate|α-Amyrin acetate|863-76-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:19抑制剂α-Lapachone|α-Lapachone|4707-33-9|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:19抑制剂α-Lapachone|α-Lapachone|4707-33-9|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:19抑制剂Z-VAD-FMK|Z-VAD-FMK|161401-82-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:19抑制剂Z-VAD-FMK|Z-VAD-FMK|161401-82-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:19抑制剂α-Amyrin acetate|α-Amyrin acetate|863-76-3|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:19抑制剂α-Amyrin acetate|α-Amyrin acetate|863-76-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:19抑制剂ZSTK474|ZSTK474|475110-96-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:19抑制剂ZSTK474|ZSTK474|475110-96-4|Adamas life|≥98%（以实测数值为准）|BR|500mg
- 2024-08-20 02:19抑制剂Z-VAD-FMK|Z-VAD-FMK|161401-82-7|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:19抑制剂ZM323881|ZM323881|193001-14-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
